Considering that a relationship has been implied between the hERG channel genotypes and drug-induced arrhythmia [59], integration of the present BLM microarray with various hERG genotypes will provide a novel and efficient screening platform for assessing the potential risks of side effects of drugs acting on respective hERG channel genotypes. The gene discussed is KCNH2; the disease is Arrhythmia.